
Tenebliz M 500mg/20mg Tablet SR
Marketer
Troikk Cardiac Care Ltd
Salt Composition
Metformin (500mg) + Teneligliptin (20mg)
Overview Tenebliz M 500mg/20mg Tablet SR
Diabetol Duo 500mg/20mg Extended-Release Tablets combine two active ingredients to manage elevated blood glucose in individuals with type 2 diabetes. This dual action helps mitigate severe diabetic complications like renal impairment and vision loss, potentially lowering the risk of cardiovascular events. Diabetol Duo may be prescribed as monotherapy or in conjunction with other antidiabetic agents. Optimal efficacy requires adherence to a balanced diet and regular physical activity. Dosage is individualized based on your health status, glucose levels, and concurrent medications. Taking the tablets with food minimizes gastrointestinal distress. Consistent daily dosing at the same time maximizes therapeutic benefit; discontinuation should only occur under medical supervision. Effective blood sugar control significantly reduces the likelihood of future complications. Continued commitment to the prescribed diet and exercise regimen is vital. Lifestyle choices significantly impact diabetes management. Commonly reported side effects include nausea, vomiting, diarrhea, abdominal discomfort, and headache. Hypoglycemia is a potential adverse effect, particularly when used with insulin or sulfonylureas; familiarity with hypoglycemia recognition and management is crucial. This medication isn't universally suitable. Inform your physician of any pre-existing kidney, liver, or heart conditions, pancreatic disorders, or significant alcohol consumption before commencing treatment. Pregnant or lactating individuals should seek medical advice prior to use. Drug interactions are possible; disclose all medications to your doctor to ensure safety. Alcohol should be minimized due to its potential to exacerbate hypoglycemia. Your doctor will monitor renal function and blood glucose levels throughout the treatment period.
Primary Ingredients of Tenebliz M 500mg/20mg Tablet SR
No information provided. Please provide the text you wish me to rephrase.
Uses of Tenebliz M 500mg/20mg Tablet SR
Managing type 2 diabetes
Major Benefits of Tenebliz M 500mg/20mg Tablet SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for Tenebliz M 500mg/20mg SR Tablets. Ingest the tablets whole; do not crush, chew, or fracture them. Administer this medication with a meal.
Common Side effects of Tenebliz M 500mg/20mg Tablet SR:
- Nausea
- Vomiting
- Headache
- Hypoglycemia (low blood glucose level)
- Diarrhea
How to use Tenebliz M 500mg/20mg Tablet SR:
Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the entire tablet without chewing, crushing, or fracturing. Consume Tenebliz M 500mg/20mg Extended-Release tablets with a meal.
How Tenebliz M 500mg/20mg Tablet SR works:
Tenebliz M, a sustained-release tablet (500mg/20mg), combines two distinct antidiabetic agents.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol alongside Tenebliz M 500mg/20mg SR tablets is unsafe.
PregnancyCONSULT YOUR DOCTOR
The extended-release Tenebliz M 500mg/20mg tablet may pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible hazards prior to prescription. Patient consultation with their doctor is advised.
Breast feedingCONSULT YOUR DOCTOR
The extended-release Tenebliz M 500mg/20mg tablet is likely unsafe for breastfeeding mothers. Preliminary human evidence indicates potential transfer to breast milk with the possibility of infant harm.
DrivingCONSULT YOUR DOCTOR
Driving ability may be affected by Tenebliz M 500mg/20mg Tablet SR, though this is unconfirmed. Refrain from driving if experiencing symptoms impairing concentration or reaction time.
KidneyCAUTION
Patients with impaired kidney function should use Tenebliz M 500mg/20mg SR tablets cautiously, potentially requiring dosage modification. Consult your physician for guidance. Tenebliz M 500mg/20mg SR tablets are contraindicated in patients with severe kidney disease. Regular kidney function monitoring is recommended during treatment.
LiverUNSAFE
Use of Tenebliz M 500mg/20mg sustained-release tablets is likely inadvisable for individuals with hepatic impairment and should be avoided. Physician consultation is recommended.
What if you forget to take Tenebliz M 500mg/20mg Tablet SR :
Should you forget a dose of Tenebliz M 500mg/20mg Extended-Release Tablet, take it promptly. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Tenebliz M 500mg/20mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
